Registry of Cardiovascular Disease Patients

N/AEnrolling By InvitationNCT01759225

Maccabi Healthcare Services, Israel110,000 enrolled

Overview

A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution. The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Study Type

OBSERVATIONAL

Enrollment

110,000

Conditions

Ischemic Heart Disease Congestive Heart Failure Peripheral Vascular Disease Cerebrovascular Disease Atrial Fibrillation Cerebrovascular Atherosclerosis

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical Diagnosis of the following: Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis. * Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes Exclusion Criteria: * patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication * Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

Locations (1)

Maccabi Healthcare Services

Tel Aviv, Israel

Outcomes

Primary Outcomes

Number of Patients with Cardiovascular disease

Time frame: Up to 100 years

Secondary Outcomes

prevalence rates of CVD

Time frame: up to 100 years

Major Adverse Cardiac Events

Time frame: up to 100 years

Number of LDL Tests performed reaching target LDL

Time frame: up to 100 years

Proportion of dyslipidemia patients treated with Statins

Time frame: up to 100 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.